SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-124231
Filing Date
2019-04-29
Accepted
2019-04-29 10:57:01
Documents
12
Period of Report
2019-04-29

Document Format Files

Seq Description Document Type Size
1 6-K d729228d6k.htm 6-K 16204
2 EX-99.1 d729228dex991.htm EX-99.1 28332
3 EX-99.2 d729228dex992.htm EX-99.2 26297
4 EX-99.3 d729228dex993.htm EX-99.3 26938
5 EX-99.4 d729228dex994.htm EX-99.4 670482
6 EX-99.5 d729228dex995.htm EX-99.5 37174
7 GRAPHIC g729228dsp010.jpg GRAPHIC 2770
8 GRAPHIC g729228g0429140250934.jpg GRAPHIC 2535
9 GRAPHIC g729228g82c28.jpg GRAPHIC 2523
10 GRAPHIC g729228page034.jpg GRAPHIC 257061
11 GRAPHIC g729228page035.jpg GRAPHIC 314875
12 GRAPHIC g729228page036.jpg GRAPHIC 230599
  Complete submission text file 0001193125-19-124231.txt   1923632
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 19774341
SIC: 2834 Pharmaceutical Preparations